Description
This 2-hour eCME program is an update lesson on the availability of new options in the management of Type 2 Diabetes. With the introduction of next-generation long-acting insulin analogues and fixed-ratio combinations of basal insulin and GLP-1 receptor agonists (GLP-1 RA), people with diabetes have an increasing number of treatment options to achieve glycemic control. This program will update healthcare professionals on the management of T2DM with long-acting basal analogues and therapeutic intensification with combinations of basal insulin and GLP-1 RA